Luke Nathaniel Walker - Jan 7, 2024 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
Chief Medical Officer
Signature
/s/ Frank J. Lanza, Attorney-in-Fact
Stock symbol
HARP
Transactions as of
Jan 7, 2024
Transactions value $
$0
Form type
4
Date filed
1/9/2024, 04:30 PM
Previous filing
Nov 28, 2023
Next filing
Mar 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HARP Common Stock Award $0 +115K +575% $0.00 135K Jan 7, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The grant of restricted stock units ("RSUs") to the Reporting Person as reported herein was approved by the Issuer's Compensation Committee on January 7, 2024 ("Grant Date") as part of the Issuer's annual grant of equity awards in the ordinary course. Each RSU represents a contingent right to receive one share of the Issuer's common stock, issuable upon the vesting and settlement of RSUs.
F2 The RSUs vest quarterly over four years from the Grant Date, subject to acceleration and vesting in full upon a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer, and subject to the continuing service of the Reporting Person on each vesting date.